Grand Brilliance Group Holdings Ltd is an investment holding company primarily engaged in the supply of medical devices. The Company also provides medical device solutions, including market trend analysis, medical device procurement, after-sales service, technical support and training, medical device rental services, and quality assurance. The Company primarily sells medical device products, including medical consumables, medical equipment, and medical devices. In addition, the Company also offers repair services and medical device rental services.

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

08:00am - Ex-dividend date - 0.0025 HKD

More about the company

Quotes

Date	Price	Change	Volume
13/07/26	HK$0.1370	+0.37%	310,000
10/07/26	HK$0.1390	0.00%	0
09/07/26	HK$0.1390	0.00%	20,000
08/07/26	HK$0.1390	0.00%	40,000
07/07/26	HK$0.1390	0.00%	0

Delayed Quote Hong Kong S.E.

More quotes

Income Statement and Estimates

More financial data

Delayed Hong Kong S.E. Other stock markets 07:45:33 13/07/2026 +04			5-day change	1st Jan Change
0.1370 ^HKD	+0.37%		-1.44%	+4.58%

06-26	Grand Brilliance Group Holdings Limited Announces Interim Ordinary Cash Dividend for the Financial Year End 31 March 2026, Payable on August 10, 2026	CI
06-26	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI

Market Cap	105M 13.37M 11.69M 10.78M 9.96M 18.9M 1.27B 19.22M 129M 50.6M 628M 50.19M 49.1M 2.16B	P/E 2024	10.2x	P/E 2025	9.13x
Enterprise Value	42.43M 5.41M 4.73M 4.37M 4.03M 7.65M 516M 7.78M 52.18M 20.49M 254M 20.32M 19.88M 874M	EV / Sales 2024	0.22x	EV / Sales 2025	0.25x
Free-Float	27.02%	Yield 2024	2.5%	Yield 2025	2.31%

06-26	Grand Brilliance Group Holdings Limited Announces Interim Ordinary Cash Dividend for the Financial Year End 31 March 2026, Payable on August 10, 2026	CI
06-26	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
11-21	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI
21/06/25	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
20/06/25	Grand Brilliance Group Holdings Limited Announces Interim Dividend for the Financial Year End 31 March 2025, Payable on August 11, 2025	CI
27/05/25	Grand Brilliance Group Holdings Limited Announces Board and Committee Changes, Effective 1 June 2025	CI
14/03/25	Grand Brilliance Group Holdings Limited Announces Resignation of Mr. Mui Wai Sum as Independent Non-Executive Director and Chairman and Member of the Audit Committee and Member of Remuneration Committee	CI
08/11/24	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2024	CI
28/06/24	Grand Brilliance Group Holdings Limited Declares Interim Dividend for the Year Ended 31 March 2024, Payable on or Before 12 August 2024	CI
28/06/24	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
13/11/23	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI
15/09/23	Grand Brilliance Group Holdings Limited Announces Board Changes, Effective September 18, 2023	CI
11/08/23	Grand Brilliance Group Holdings Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	CI

1 day	+0.37%
1 week	-1.44%
Current month	-2.14%
1 month	-9.87%
3 months	+9.60%
6 months	+6.20%
Current year	+4.58%

Grand Brilliance Group Holdings Limited Stock

Stocks

8372

KYG4136R1020

Medical Equipment, Supplies & Distribution

Valuation: Grand Brilliance Group Holdings Limited

Chart: Grand Brilliance Group Holdings Limited

Latest news : Grand Brilliance Group Holdings Limited

Quotes and Performance

Course Extremes

Managers and Directors: Grand Brilliance Group Holdings Limited

Medical Equipment Wholesale

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	0.13	0.14
1 month	0.13	0.16
Current year	0.12	0.18
1 year	0.1	0.18
3 years	0.07	0.18
5 years	0.06	0.18
10 years	0.06	0.57

Manager	Title	Age	Since
Bik Kwan Wong CEO	Chief Executive Officer	57	01/03/2018
Chong Chi Cheung DFI	Director of Finance/CFO	48	-
Wai Man Lau SAM	Sales & Marketing	39	01/02/2015

Director	Title	Age	Since
Bik Kwan Wong CHM	Chairman	57	01/03/2018
Yin Shun Miu BRD	Director/Board Member	59	18/09/2017
Man Wai Chiu BRD	Director/Board Member	57	18/09/2017

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GRAND BRILLIANCE GROUP HOLDINGS LIMITED	+0.37%	-1.44%	+18.10%	+69.14%	14.18M
HENRY SCHEIN, INC.	+0.64%	-2.35%	+14.96%	+3.52%	9.61B
SHIP HEALTHCARE HOLDINGS, INC.	+1.24%	-0.24%	+12.26%	+1.17%	1.29B
SHANGHAI C&D INNOSTIC MEDICAL TECHNOLOGY GROUP CO., LTD.	+1.53%	-2.98%	-	-	1.28B
AS ONE CORPORATION	+0.77%	+3.07%	+1.93%	-12.13%	1.07B
COWEALTH MEDICAL CHINA CO.,LTD.	+4.29%	-6.79%	+52.42%	+29.07%	628M
GKHT MEDICAL TECHNOLOGY CO., LTD.	+3.53%	+0.12%	-22.73%	-67.41%	585M
NIPPON CARE SUPPLY CO., LTD.	-1.04%	-0.23%	+103.57%	+159.09%	416M
EXCELSIOR MEDICAL CO., LTD.	+0.72%	+0.43%	-12.75%	-15.30%	410M
ACCENDRA HEALTH, INC.	+3.64%	-4.74%	-57.88%	-81.49%	262M
Average	+1.57%	-1.07%	+12.21%	+9.52%	1.56B
Weighted average by Cap.	+1.03%	-1.67%	+14.29%	+2.85%

	2024	2025
Net sales	81.9M 10.45M 9.14M 8.43M 7.78M 14.77M 996M 15.02M 101M 39.55M 491M 39.22M 38.37M 1.69B	94.45M 12.05M 10.54M 9.72M 8.98M 17.03M 1.15B 17.32M 116M 45.6M 566M 45.23M 44.25M 1.95B
Net income	7.86M 1M 876K 808K 747K 1.42M 95.56M 1.44M 9.66M 3.79M 47.07M 3.76M 3.68M 162M	9.46M 1.21M 1.06M 974K 899K 1.71M 115M 1.73M 11.63M 4.57M 56.69M 4.53M 4.43M 195M
Net Debt	-61.91M -7.9M -6.91M -6.37M -5.88M -11.17M -753M -11.35M -76.13M -29.9M -371M -29.65M -29.01M -1.28B	-62.36M -7.95M -6.96M -6.42M -5.93M -11.25M -759M -11.44M -76.68M -30.11M -374M -29.87M -29.22M -1.28B